Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

69
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
69
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

67
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
67
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

59
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
59
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

58
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
58
Antimicrobial Proteins01:23

Antimicrobial Proteins

14.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.9K
Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

80
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bioinspired Mastoparan Exhibits Concentration-Dependent Anti-Bacterial Activity via Membrane Disruption.

ACS applied materials & interfaces·2025
Same author

Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery.

Journal of visualized experiments : JoVE·2025
Same author

Non-invasive tape sampling of tryptophan and kynurenine in relation to phenylalanine and tyrosine from melanoma and adjacent non-lesional skin: A pilot study.

PloS one·2025
Same author

Combining functionalities-nanoarchitectonics for combatting bacterial infection.

Advances in colloid and interface science·2024
Same author

Computational Approaches for Antimicrobial Peptide Delivery.

Bioconjugate chemistry·2024
Same author

Photocatalytic Degradation of Bacterial Lipopolysaccharides by Peptide-Coated TiO<sub>2</sub> Nanoparticles.

ACS applied materials & interfaces·2024

Related Experiment Video

Updated: Mar 8, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K

Delivery systems for antimicrobial peptides.

Randi Nordström1, Martin Malmsten2

  • 1Department of Pharmacy, Uppsala University, P.O. Box 580, SE-751 23 Uppsala, Sweden.

Advances in Colloid and Interface Science
|February 5, 2017
PubMed
Summary
This summary is machine-generated.

Novel delivery systems are crucial for developing effective antimicrobial peptide (AMP) therapeutics. These systems enhance AMP stability, reduce side effects, and improve treatment efficacy against resistant infections.

Keywords:
Antimicrobial peptideDrug deliveryInfection

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Materials Science

Background:

  • Antibiotic resistance necessitates novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) show promise but require effective delivery systems.
  • Current research on AMP delivery lags behind peptide discovery and optimization.

Purpose of the Study:

  • To provide an overview of antimicrobial peptide delivery systems.
  • To focus on AMP-carrier interactions and their biological consequences.
  • To highlight the importance of delivery systems for AMP-based therapeutics.

Main Methods:

  • Literature review on antimicrobial peptide delivery systems.
  • Analysis of AMP-carrier interactions.
  • Evaluation of the impact of delivery systems on AMP efficacy and safety.

Main Results:

  • Delivery systems can protect AMPs from degradation.
  • Controlled release mechanisms can optimize AMP therapeutic effects.
  • Delivery systems can enhance biofilm penetration and target intracellular pathogens.

Conclusions:

  • Delivery systems are essential for realizing the full potential of antimicrobial peptides.
  • Understanding AMP-carrier interactions is key to designing effective formulations.
  • Advanced delivery strategies are critical for combating antibiotic resistance.